Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on: January 30,2024

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on:January 30,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Updated on: February 01,2024

Researchers pinpoint potential treatment for lethal childhood cancer

by McMaster UniversityCredit: Unsplash/CC0 Public DomainAn enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster Universi

Updated on:February 01,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on: January 30,2024

Research perspective: Cancer prevention with rapamycin

by Impact Journals LLCRapamycin prevents cancer by slowing tumor progression (hypothetical schema). (A) Rapamycin slows tumor progression and delays cancer and death from cancer. (B) Rapamycin slows t

Updated on:January 30,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on: November 11,2024

New model shows potential for human papillomavirus vaccination switch to 1-dose gender-neutral approach

byCanadian Medical Association JournalCredit: Unsplash/CC0 Public DomainCanadian vaccination programs could switch to a 1-dose gender-neutral human papillomavirus (HPV) vaccination approach and

Updated on:November 11,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on: June 01,2024

Researchers trace timeline of tumor evolution in metastatic breast cancer patients

by University of Utah Health SciencesTheresa Werner, MD, Medical Director of the Clinical Trials Office at Huntsman Cancer Institute and Associate Professor of Medicine at the University of Utah.

Updated on:June 01,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on: May 23,2024

Drug combination shows promise in preclinical models of triple negative breast cancer

by Alhaji Janneh,Medical University of South CarolinaYueying Liu and Dr. Antonio Giordano study PLK1 inhibitors, traffic light-like signals that stop the uncontrolled growth of breast cancer cel

Updated on:May 23,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on: January 02,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on:January 02,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on: March 01,2024

Research identifies cells that may be responsible for prostate cancer recurrence

by Roswell Park Cancer InstituteSlide illustrating resistance to androgen-deprivation therapy in a newly identified population of dormant prostate luminal stem cells. Credit: Roswell Park Cancer

Updated on:March 01,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on: December 28,2023

Rhombic lip implicated in origins of high-risk medulloblastoma

bySt. Jude Children's Research HospitalTranscriptional atlas of the human fetal cerebellum. (a) Schematic summary of the molecular datasets used to interconnect mouse and human cerebellar pr

Updated on:December 28,2023